IP litigator who leverages life sciences expertise to secure results
In her intellectual property (IP) litigation practice, Chen leverages her top notch legal skills and technical expertise to deliver insightful work products for clients. With a focus on life sciences, she is involved in all aspects of litigation and regulation, including drafting court documents, corresponding with expert witnesses and preparing opinions. In her work, she continually explores new areas of science and emerging technology.
In addition to litigation, Chen also assists in patent prosecution, and related strategic counseling and due diligence.
Before entering law, Chen worked as a research scientist at multiple labs, conducting research on fibroproliferative diseases, DNA repair mechanisms, stem cell therapy and micro-RNA technology. She has experience managing various challenging research projects, all of which resulted in successful publication in leading journals, including Nature. This experience helped her build the scientific rigor with which she practices law.
During her legal studies, Chen actively volunteered within the legal community, working with the Health Professions Appeal and Review Board, as a pro-bono extern for the Structural Genomics Consortium and as an assistant editor with the University of Toronto Faculty of Law Review. Chen also co-authored “Drawing the Line between Lay and Expert Opinion Evidence,” a paper on expert opinion evidence that resulted in publication in the McGill Law Journal.
- In the Media
- "Canada’s Response to COVID-19: From regulatory flexibility to reimbursement changes, how regulators and payers are managing the COVID-19 crisis" (co-author: Alice Tseng), LMG Life Sciences, April 24, 2020
- “Drawing the Line between Lay and Expert Opinion Evidence” (co-authors: Chin, J. and Tomiska, J.), McGill Law Journal. 2017; 63:1